Vericel Corp VCEL

NAS: VCEL | ISIN: US92346J1088 30/04/2025

38,02 USD (-3,40%)

(-3,40%) 30/04/2025

Grafiek Vericel Corp

Grafiek Vericel Corp

1 dag1d -3,40%
1 week1w -7,47%
1 maand1m -11,76%
3 maanden3m -35,62%
6 maanden6m -13,57%
1 jaar1j -19,24%
5 jaar5j 171,38%

donderdag 8 mei 2025, 13:55

Kwartaalcijfers (1ste kwartaal)

Vericel Corp in het nieuws

Toon enkel gratis nieuws

2 mei 2023 · Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor · Persbericht

17 maart 2021 · Vericel Set to Join S&P SmallCap 600 · Persbericht

10 maart 2021 · Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 · Persbericht

22 februari 2021 · Vericel to Present at the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 · Persbericht

16 februari 2021 · Vericel to Participate in the BTIG Virtual MedTech Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021 · Persbericht

12 februari 2021 · Vericel Announces Termination of Shareholder Rights Agreement · Persbericht

11 januari 2021 · Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates · Persbericht

8 januari 2021 · Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021 · Persbericht

7 januari 2021 · Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee · Persbericht

Profiel Vericel Corp

Gezondheidstechnologie

Medische Specialiteiten

Productie van biologische producten

Website: vcel.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

CEO: Dominick Colangelo

Werknemers: 305

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe